U.S. to test supplement against Parkinson’s disease

Early research suggests creatine supplements might be able to help slow the progression of Parkinson’s, an incurable brain disorder that can slowly but steadily paralyze patients.

The National Institute of Neurological Disorders and Stroke, one of the U.S.

National Institutes of Health, is launching the trial as the first in a series of government-sponsored studies of new Parkinson’s treatments.

Many clinical studies in the United States are sponsored by drug companies, which means that often only medicines they can make money on get tested.

The NINDS will recruit 1,720 people with early-stage Parkinson’s disease across the United States and Canada. Patients and doctors alike will not know whether they are getting creatine or a placebo. The study is due to last three to five years.

“This study is an important step toward developing a therapy that could change the course of this devastating disease,” said NIH Director Dr. Elias Zerhouni.
Read More….


Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: